Tweet
APR 15 2021
More than 170 former heads of state and government and Nobel laureates, called on President Biden to support a waiver of intellectual property rules for COVID-19 vaccines and pursue a people?s vaccine to end the pandemic in an open letter sent today. Signatories include former Prime Minister of the United Kingdom Gordon Brown, former President of Ireland Mary Robinson, former President of France Fran?ois Holland, former Prime Minister of New Zealand Helen Clark, former President of Brazil Fernando Henrique Cardoso, and former President of Malawi Joyce Banda, all Members of Club de Madrid, together with over 60 other former heads of state and government that span every continent. Nobel Laureates Professor Joseph Stiglitz, Professor Elizabeth H. Blackburn and Professor Muhammad Yunus are also part of the call to Biden.
The letter was sent to the White House as U.S. health authorities advised a pause in the use of the Johnson & Johnson Covid-19 vaccine. A waiver of intellectual property rules would allow for a scale up in manufacturing in the U.S. and around the world, overcoming artificial supply constraints. ...
More than 170 former heads of state and government and Nobel laureates, called on President Biden to support a waiver of intellectual property rules for COVID-19 vaccines and pursue a people?s vaccine to end the pandemic in an open letter sent today. Signatories include former Prime Minister of the United Kingdom Gordon Brown, former President of Ireland Mary Robinson, former President of France Fran?ois Holland, former Prime Minister of New Zealand Helen Clark, former President of Brazil Fernando Henrique Cardoso, and former President of Malawi Joyce Banda, all Members of Club de Madrid, together with over 60 other former heads of state and government that span every continent. Nobel Laureates Professor Joseph Stiglitz, Professor Elizabeth H. Blackburn and Professor Muhammad Yunus are also part of the call to Biden.
The letter was sent to the White House as U.S. health authorities advised a pause in the use of the Johnson & Johnson Covid-19 vaccine. A waiver of intellectual property rules would allow for a scale up in manufacturing in the U.S. and around the world, overcoming artificial supply constraints. ...